Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
about
Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns.Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit assay and the National Genetics Institute HCV Superquant assayHighly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.Comparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination TherapyImmunodiagnosis of viral hepatitides A to E and non-A to -ESerum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological featuresPrevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patientsTracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipientsModeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacyComparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitationMarkers of viral infection in monozygotic twins discordant for chronic fatigue syndromeNovel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patientsExpertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serumRisk and management of blood-borne infections in health care workers.Genotype and viral load as prognostic indicators in the treatment of hepatitis C.Treatment of chronic hepatitis C: a systematic review.Molecular and contextual markers of hepatitis C virus and drug abuse.Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virusClinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus.SASLT practice guidelines: management of hepatitis C virus infection.Hepatitis C virus quantitation: optimization of strategies for detecting low-level viremia.Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.Case report: acute encephalitis immediately prior to acute onset of hepatitis C virus infection.Laboratory diagnosis of hepatitis C.Managing patients on interferon therapy.Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C.Reverse transcriptase-polymerase chain reaction fails to detect peripheral-blood hepatitis C RNA in formalin-fixed liver tissue.A case-control study of the factors associated with spontaneous resolution of hepatitis C viremia.Comparative study of a modified competitive RT-PCR and Amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum.A comparison of reverse transcription-polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment. Consensus Interferon Study Group.A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.Standardization of hepatitis C virus--RNA quantification: advances and unfinished business.Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection.Hepatitis C infection during treatment for childhood cancer: pitfalls in diagnosis and management.Therapy for chronic hepatitis B and C infection in haemophilia.
P2860
Q27469364-5BA53BE6-6222-433E-8DED-2E716896346EQ27469549-A8C0020B-CB99-40E6-A5F0-56130ECDDC7DQ27469589-93381F51-60D9-4B5B-88A8-561929054FE5Q27471191-24081B36-4A01-476A-AC90-4B1A96048178Q27471239-3688E9D3-CFAC-4491-B5B1-AC2EE6B0FB36Q27477674-DA7A2C9C-B012-4B10-8A61-D1463CA781C3Q27477783-00DA3670-E6D3-461B-8FD7-AC4842E0F2CAQ27477831-554FB3B1-34D7-44E3-A5C0-5A5A4716BAF1Q27477958-EFEF2D64-62FB-47BA-82D2-674992838A52Q27480747-E1A34039-6F7D-410B-8CAC-7C491FDF5B48Q27485474-C4DD4EC9-B6F6-48A4-85A2-EBDE25BA93F1Q27485763-03011157-AB30-4FE9-B37D-71BDD4A737FAQ28217481-85DE1AC3-D5FA-402D-8C5B-B658D77B4065Q33592762-C330A137-BD51-430E-8C6B-8B4EB07139B4Q33712557-330B106B-ED08-4F7C-8028-25EBAE634B68Q33961883-8A430705-E508-4D55-8086-A316ABF3D18AQ33962266-00240F10-3DB8-45F3-9986-915F9E2FDC7BQ34984085-3F19E963-3FF1-4CAB-B6FE-6F07588D9BE1Q35660841-1AD6EF05-07E1-4D96-B5BC-AA4DB40181DDQ36241203-E93C01CD-D088-46F7-AC79-85AE05907FF6Q36537170-2E69679C-5D2E-4699-8E6A-2615BC1C7AC2Q37019765-F9E152DC-67E9-4E43-8A0F-D70D27FCF4CCQ39455553-7AC4EF87-9DC7-469E-AD65-C4940F6CC5B1Q39458171-4847B00C-FE26-464B-AF22-A0632BCAF18CQ39459300-30622FE5-1636-4D4C-A02C-462349CAC2F0Q40788790-8F011F70-3732-4439-B3AC-36302A644B97Q41351271-3BC4227C-0CC7-49E4-9983-0AA6D9979FD5Q42981058-06346C85-87AF-4305-A194-789889B26102Q42982137-444A37A4-F821-43E4-B42C-78BEA23C7667Q42990580-F38F009F-0366-4919-987B-9C3E88638ED8Q42992650-DEEC3518-FDFF-4D67-89C2-1BBA5A751A75Q42993283-35F7C886-6315-4532-B849-8E87913A6009Q42996547-C549141C-6D50-48CA-A669-0EE185A22076Q42997607-EB753738-9F88-4212-A508-327654CF6DF8Q42997630-6F236C0E-02C9-48F5-B959-839549111040Q43036608-C08AA445-7C56-40FD-B251-DF64ED269F86Q45245822-2CADF56E-FC6B-4F58-B5C2-5CD3011042E2Q45855058-9A2D6282-E6DD-407F-855C-06DEC27564E9
P2860
Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Assessment of hepatitis C vire ...... ons and clinical implications.
@en
Assessment of hepatitis C vire ...... ons and clinical implications.
@nl
type
label
Assessment of hepatitis C vire ...... ons and clinical implications.
@en
Assessment of hepatitis C vire ...... ons and clinical implications.
@nl
prefLabel
Assessment of hepatitis C vire ...... ons and clinical implications.
@en
Assessment of hepatitis C vire ...... ons and clinical implications.
@nl
P2093
P1476
Assessment of hepatitis C vire ...... ons and clinical implications.
@en
P2093
Carithers RL Jr
Williams B
Willson RA
dela Rosa C
P304
P356
10.7326/0003-4819-123-5-199509010-00001
P407
P577
1995-09-01T00:00:00Z